KR101050076B1 - 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법 - Google Patents

제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법 Download PDF

Info

Publication number
KR101050076B1
KR101050076B1 KR1020090008830A KR20090008830A KR101050076B1 KR 101050076 B1 KR101050076 B1 KR 101050076B1 KR 1020090008830 A KR1020090008830 A KR 1020090008830A KR 20090008830 A KR20090008830 A KR 20090008830A KR 101050076 B1 KR101050076 B1 KR 101050076B1
Authority
KR
South Korea
Prior art keywords
aceclofenac
release
sustained
tablet
drug
Prior art date
Application number
KR1020090008830A
Other languages
English (en)
Korean (ko)
Other versions
KR20100089532A (ko
Inventor
이범진
최연웅
민병구
안승호
Original Assignee
한국유나이티드제약 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국유나이티드제약 주식회사 filed Critical 한국유나이티드제약 주식회사
Priority to KR1020090008830A priority Critical patent/KR101050076B1/ko
Priority to RU2011132480/15A priority patent/RU2493843C2/ru
Priority to CN2009801560737A priority patent/CN102307575B/zh
Priority to PCT/KR2009/002251 priority patent/WO2010090371A1/en
Priority to EP09839738A priority patent/EP2393486A4/en
Publication of KR20100089532A publication Critical patent/KR20100089532A/ko
Application granted granted Critical
Publication of KR101050076B1 publication Critical patent/KR101050076B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020090008830A 2009-02-04 2009-02-04 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법 KR101050076B1 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1020090008830A KR101050076B1 (ko) 2009-02-04 2009-02-04 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
RU2011132480/15A RU2493843C2 (ru) 2009-02-04 2009-04-20 Содержащие ацеклофенак пероральные лекарственные средства с контролируемым высвобождением и способ их изготовления
CN2009801560737A CN102307575B (zh) 2009-02-04 2009-04-29 含醋氯芬酸的控释口服药制剂及其制造方法
PCT/KR2009/002251 WO2010090371A1 (en) 2009-02-04 2009-04-29 Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process
EP09839738A EP2393486A4 (en) 2009-02-04 2009-04-29 ACECLOFENAC-CONTAINING ORAL MEDICAMENT PREPARATIONS WITH CONTROLLED RELEASE AND ITS MANUFACTURING PROCESS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090008830A KR101050076B1 (ko) 2009-02-04 2009-02-04 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법

Publications (2)

Publication Number Publication Date
KR20100089532A KR20100089532A (ko) 2010-08-12
KR101050076B1 true KR101050076B1 (ko) 2011-07-19

Family

ID=42542247

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090008830A KR101050076B1 (ko) 2009-02-04 2009-02-04 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법

Country Status (5)

Country Link
EP (1) EP2393486A4 (ru)
KR (1) KR101050076B1 (ru)
CN (1) CN102307575B (ru)
RU (1) RU2493843C2 (ru)
WO (1) WO2010090371A1 (ru)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107964454A (zh) * 2017-12-21 2018-04-27 广州合诚三先生物科技有限公司 一种油溶的迷迭香抗氧化剂及其制备方法
KR20200121591A (ko) 2019-04-16 2020-10-26 한국유나이티드제약 주식회사 아세클로페낙을 포함하는 약학조성물 및 이의 제조방법

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101234254B1 (ko) * 2010-06-01 2013-02-18 한국유나이티드제약 주식회사 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제
KR20120092993A (ko) * 2011-02-14 2012-08-22 지엘팜텍 주식회사 티아넵틴 또는 이의 약제학적으로 허용되는 염을 포함하는 경구투여용 서방성 정제
KR20130117128A (ko) * 2012-04-17 2013-10-25 한국유나이티드제약 주식회사 레보드로프로피진 함유 서방정 및 이의 제조방법
MX348595B (es) * 2013-08-02 2017-06-21 Laboratorio Raam De Sahuayo S A De C V Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion.
KR102126282B1 (ko) * 2018-08-28 2020-07-08 울산과학기술원 중공형 나노구조체를 이용한 상온구동형 가스센서 및 이의 제조방법

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030003500A (ko) * 2001-07-03 2003-01-10 이범진 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
CN1239162C (zh) * 2004-02-05 2006-02-01 晏四平 治疗疼痛的药物组合物
WO2008109018A1 (en) * 2007-03-02 2008-09-12 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
CN100528144C (zh) * 2007-07-13 2009-08-19 浙江尖峰药业有限公司 醋氯芬酸缓释片及其制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030003500A (ko) * 2001-07-03 2003-01-10 이범진 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107964454A (zh) * 2017-12-21 2018-04-27 广州合诚三先生物科技有限公司 一种油溶的迷迭香抗氧化剂及其制备方法
CN107964454B (zh) * 2017-12-21 2021-03-26 广州合诚三先生物科技有限公司 一种油溶的迷迭香抗氧化剂及其制备方法
KR20200121591A (ko) 2019-04-16 2020-10-26 한국유나이티드제약 주식회사 아세클로페낙을 포함하는 약학조성물 및 이의 제조방법

Also Published As

Publication number Publication date
EP2393486A1 (en) 2011-12-14
WO2010090371A1 (en) 2010-08-12
RU2011132480A (ru) 2013-03-10
RU2493843C2 (ru) 2013-09-27
CN102307575A (zh) 2012-01-04
KR20100089532A (ko) 2010-08-12
CN102307575B (zh) 2013-02-13
EP2393486A4 (en) 2012-10-10

Similar Documents

Publication Publication Date Title
KR101050076B1 (ko) 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
EP2448561B1 (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
JP2009079034A (ja) 新規のナイアシン制御放出型製剤
KR101234254B1 (ko) 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제
EP3013327A1 (en) Pharmaceutical capsule composite formulation comprising tadalafil and tamsulosin
CN109875972B (zh) 一种奥美沙坦酯氨氯地平药物组合物
US20200146977A1 (en) Pharmaceutical Composition for Oral Administration Comprising Enzalutamide
KR20040006887A (ko) 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
KR101076648B1 (ko) 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
KR20010072269A (ko) 이부프로펜 및 돔페리돈을 포함하는 약제학적 조성물
ES2963886T3 (es) Comprimidos que contienen tamsulosina y solifenacina
TWI436760B (zh) 阿利克侖之蓋崙（ｇａｌｅｎｉｃａｌ）調配物
WO2008101375A1 (fr) Composition pharmaceutique de rétention gastrique à libération prolongée comprenant de l'irbesartan
KR101093781B1 (ko) ｐＨ조절제를 함유하는 목시플록사신 고형 조성물
WO2020109319A1 (en) Pharmaceutical composition comprising ramipril and indapamide
EP2682109B1 (en) Combined immediate release formulations of flurbiprofen and famotidine
KR100754239B1 (ko) 염산세티리진과 염산슈도에페드린을 함유하는 제어방출성의 경구용 제제 및 그의 제조방법
KR100911517B1 (ko) 신규한 서방출형 아세클로페낙 제제 조성물 및 그의제조방법
RU2354358C1 (ru) Твердая лекарственная форма матричного типа, обладающая противовоспалительной, анальгезирующей, жаропонижающей активностью, с пролонгированным высвобождением, и способ ее получения
CN114306263B (zh) 一种复方降压药物组合物及其制备方法
KR101944085B1 (ko) 발사르탄 함유 고형 경구제형 및 그 제조방법
CA3200729A1 (en) Pharmaceutical composition comprising meloxicam
JP2022112698A (ja) アピキサバン含有医薬組成物
KR20120090401A (ko) 잘토프로펜을 함유하는 제어방출성 제제의 조성물 및 그의 제조방법
WO2012113179A1 (zh) 一种扎托布洛芬的缓释药物组合物及其制备方法

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140728

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20150712

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20160627

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20170705

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20180621

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20190523

Year of fee payment: 9